A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
Clinical trial NCT01094184 · COMPLETED
Trial details
- NCT number
- NCT01094184
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2015-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.